Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
6.15 EUR
58.95 M EUR
111.28 M EUR
9.32 M
About SANTHERA N
Sector
CEO
Dario Eklund
Headquarters
Pratteln
Website
Founded
1998
ISIN
CH1276028821
FIGI
BBG000RCGR79
Santhera Pharmaceuticals Holding AG engages in the development and commercialization of products for the treatment of neuromuscular and pulmonary diseases. Its product pipeline includes Vamorolone and Lonodelestat. The company was founded by Thomas Meier in 1998 and is headquartered in Pratteln, Switzerland.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of S3F0 is 10.30 EUR — it has decreased by −3.74% in the past 24 hours. Watch SANTHERA PHARMACEUTICALS HOLDING LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange SANTHERA PHARMACEUTICALS HOLDING LTD. stocks are traded under the ticker S3F0.
We've gathered analysts' opinions on SANTHERA PHARMACEUTICALS HOLDING LTD. future price: according to them, S3F0 price has a max estimate of 26.62 EUR and a min estimate of 21.30 EUR. Watch S3F0 chart and read a more detailed SANTHERA PHARMACEUTICALS HOLDING LTD. stock forecast: see what analysts think of SANTHERA PHARMACEUTICALS HOLDING LTD. and suggest that you do with its stocks.
S3F0 reached its all-time high on Oct 19, 2023 with the price of 14.80 EUR, and its all-time low was 7.55 EUR and was reached on Oct 11, 2023. View more price dynamics on S3F0 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
S3F0 stock is 7.00% volatile and has beta coefficient of 0.12. Track SANTHERA PHARMACEUTICALS HOLDING LTD. stock price on the chart and check out the list of the most volatile stocks — is SANTHERA PHARMACEUTICALS HOLDING LTD. there?
Today SANTHERA PHARMACEUTICALS HOLDING LTD. has the market capitalization of 103.92 M, it has increased by 1.32% over the last week.
Yes, you can track SANTHERA PHARMACEUTICALS HOLDING LTD. financials in yearly and quarterly reports right on TradingView.
SANTHERA PHARMACEUTICALS HOLDING LTD. is going to release the next earnings report on Apr 24, 2025. Keep track of upcoming events with our Earnings Calendar.
SANTHERA PHARMACEUTICALS HOLDING LTD. revenue for the last half-year amounts to 14.64 M EUR, despite the estimated figure of 5.82 M EUR. In the next half-year revenue is expected to reach 14.70 M EUR.
S3F0 net income for the last half-year is −15.85 M EUR, while the previous report showed 84.06 M EUR of net income which accounts for −118.85% change. Track more SANTHERA PHARMACEUTICALS HOLDING LTD. financial stats to get the full picture.
No, S3F0 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 25, 2024, the company has 44.00 employees. See our rating of the largest employees — is SANTHERA PHARMACEUTICALS HOLDING LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SANTHERA PHARMACEUTICALS HOLDING LTD. EBITDA is 59.27 M EUR, and current EBITDA margin is 51.81%. See more stats in SANTHERA PHARMACEUTICALS HOLDING LTD. financial statements.
Like other stocks, S3F0 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SANTHERA PHARMACEUTICALS HOLDING LTD. stock right from TradingView charts — choose your broker and connect to your account.